Enhanced presentation of MHC class Ia, Ib and class II-restricted peptides encapsulated in biodegradable nanoparticles: a promising strategy for tumor immunotherapy
<p>Abstract</p> <p>Background</p> <p>Many peptide-based cancer vaccines have been tested in clinical trials with a limited success, mostly due to difficulties associated with peptide stability and delivery, resulting in inefficient antigen presentation. Therefore, the d...
主要な著者: | , , , , , , , , , , , |
---|---|
フォーマット: | 論文 |
言語: | English |
出版事項: |
BMC
2011-03-01
|
シリーズ: | Journal of Translational Medicine |
オンライン・アクセス: | http://www.translational-medicine.com/content/9/1/34 |